SWAV - Johnson & Johnson Strong Strategic Fit For Shockwave Medical But Medtronic Boston Scientific Could Be Other Bidder Says Analyst | Benzinga
Tuesday, Shockwave Medical Inc (NASDAQ:SWAV) shares traded higher following a Wall Street Journal report suggesting Johnson & Johnson (NYSE:JNJ) is reportedly in talks to acquire the company.
Shockwave Medical is a cardiovascular medical device.
In 2022, Johnson & Johnson acquired heart failure device-focused Abiomed Inc. for an upfront payment of $380.00 per share in cash, corresponding to an enterprise value of approximately $16.6 billion.
Piper Sandler says it has considered Johnson & Johnson a potential buyer due to its interest in expanding into cardiovascular devices and strong financial position.
Additionally, there were reports in May 2023 indicating Johnson & Johnson’s interest in acquiring ...